Publications
66
Citations
155
Est. group size
—
Recurring co-author estimate
Active years
27
Publishing since 1999
Khushali Jhaveri conducts clinical research in blood cancers (hematologic malignancies), with a focus on lymphomas such as diffuse large B-cell lymphoma and follicular lymphoma. A central theme is CAR T-cell therapy, an immune treatment that reprograms a patient's own T-cells to attack cancer, and how patient factors like muscle loss (sarcopenia), body composition, and nutrition affect treatment outcomes.
Publication activity has been uneven across the decade, with gaps in some years but notably high output in 2023 and 2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~17 · 8% small-team papers (≤3 authors) · across 21 venues
- Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma
Blood Cancer Journal · 2025
- Extranodal Natural Killer/T-Cell Lymphoma
2025
- Follicular Lymphoma
2025
- Supplementary Tables from Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy
2025
- Supplementary Figures from Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy
2025
- Bispecific antibody combination regimens for B-cell non-Hodgkin’s lymphomas
Expert Opinion on Biological Therapy · 2025
- Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
Clinical Cancer Research · 2025
- Supplementary Figure S3 from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Supplementary Figure S2 from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Supplementary Figure S5 from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Supplementary Table S6 from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Supplementary Table S4 from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Supplementary Table S5 from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Supplementary Figure S4 from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Data from Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B-cell Lymphoma
2025
- Cureus×4
- Blood×3
- CHEST Journal×3
- Gastroenterology×3
- Journal of Clinical Oncology×2
- Monalisa Ghosh
Medicine · University of Michigan
- Audrey M. Sigmund
Medicine · The Ohio State University
- Nathan Denlinger
Medicine · The Ohio State University
- Nirav N. Shah
Medicine · University of Michigan
- Amneet Bajwa
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 27, 2026.
Claim or correct this profile